MALAT1 high expression was also indicated to predict poor OS among different cancer types (Estrogen-dependent cancer: pooled HR = 2.656, 95% CI = 1.560–4.523; Urological cancer: pooled HR = 1.952, 95% CI 1.189–3.204; Glioma: pooled HR = 2.315, 95% CI 1.643–3.263; Digestive cancer: pooled HR = 2.451, 95% CI 1.862–3.227) (data shown in Table 2 and Fig. 3a). This evidence concerns the gene MALAT1 and cancer.